This compound is a pharmaceutical intermediate used in the synthesis of SGLT2 inhibitors. It features a complex fused-ring system with an amide and multiple ether functional groups, and contains one aromatic ring.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
((((E)-2-((2R,3R,4R,5R)-3-(((2-CYANOETHOXY)(DIISOPROPYLAMINO)PHOSPHINO)OXY)-5-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)-4-METHOXYTETRAHYDROFURAN-2-YL)VINYL)PHOSPHORYL)BIS(OXY))BIS(METHYLENE) BIS(2,2-DIMETHYLPROPANOATE)
pharmaceutical intermediate
Carbamic acid, cyano-, methyl ester
pharmaceutical intermediate
Methyl (Z)-3-aminobut-2-enoate
pharmaceutical intermediate
1H-Tetrazole-1-acetic acid
pharmaceutical intermediate
(2,2-dimethyl-6-phenylmethoxy-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-5-yl)-morpholin-4-ylmethanone
NHVJDEDXMVGOJC-UHFFFAOYSA-N
CC1(OC2C(C(OC2O1)C(=O)N3CCOCC3)OCC4=CC=CC=C4)C
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.